SGC, HitGen collaborate on DEL technology for drug discovery
HitGen will leverage its DNA-encoded library (DEL) technology platform for the collaboration, specifically the OpenDEL solution, a self-service…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
29 Sep 23
HitGen will leverage its DNA-encoded library (DEL) technology platform for the collaboration, specifically the OpenDEL solution, a self-service…
29 Sep 23
The FDA has cleared the muscle disorder therapy only for adult LOPD patients whose weight is ≥40kg and…
29 Sep 23
Scynexis has recalled the drug over potential risk of cross contamination with a non-antibacterial ß-lactam drug substance in…
29 Sep 23
The drug’s mechanism of targeted single serotonin (5HT) 1a receptor agonism reduced depressive symptoms with an acceptable side…
29 Sep 23
Unlocking the AI Revolution - A Symposium on the future of the Healthcare Industry and Diagnostic Imaging in…
29 Sep 23
If approved, sotatercept would be the first in its class, bringing a novel approach to address a rare…
29 Sep 23
Faster, Hyper-Accurate Commissioning and Beam Scanning Solution Now Available in Countries Requiring CE Marking
29 Sep 23
CaRi-Heart® Users share Excitement on Potential for Heart Attack Prediction and Prevention
28 Sep 23
The FDA approval was supported by the data from the MIRA trial programme in which the percentage of…
28 Sep 23
ENTYVIO Is the Only FDA-Approved Ulcerative Colitis Biologic That Offers the Choice of Intravenous or Subcutaneous Maintenance Therapy